Tolterodine Tartrate represents a high-purity active pharmaceutical ingredient specifically engineered as a muscarinic receptor antagonist for advanced urological treatments. With the chemical designation (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrate and empirical formula C26H37NO7, this compound features a molecular weight of 475.6. It presents as a white, crystalline powder characterized by a pKa value of 9.87 and demonstrates excellent water solubility at 12 mg/mL. The substance shows good solubility in methanol, slight solubility in ethanol, and practical insolubility in toluene, with a partition coefficient (Log D) of 1.83 at pH 7.3 between n-octanol and water. This API consistently meets rigorous pharmaceutical standards required for manufacturing effective anti-muscarinic medications with reliable therapeutic outcomes.

Pharmaceutical manufacturers globally utilize Tolterodine Tartrate API in developing advanced medications for overacti...

Tolterodine Tartrate represents a high-purity active pharmaceutical ingredient specifically engineered as a muscarinic receptor antagonist for advanced urological treatments. With the chemical designation (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrate and empirical formula C26H37NO7, this compound features a molecular weight of 475.6. It presents as a white, crystalline powder characterized by a pKa value of 9.87 and demonstrates excellent water solubility at 12 mg/mL. The substance shows good solubility in methanol, slight solubility in ethanol, and practical insolubility in toluene, with a partition coefficient (Log D) of 1.83 at pH 7.3 between n-octanol and water. This API consistently meets rigorous pharmaceutical standards required for manufacturing effective anti-muscarinic medications with reliable therapeutic outcomes.

Pharmaceutical manufacturers globally utilize Tolterodine Tartrate API in developing advanced medications for overactive bladder syndrome and related urological conditions. The compound serves as the fundamental active component in both branded and generic pharmaceutical products targeting urinary incontinence, frequency, and urgency symptoms. International pharmaceutical companies incorporate this API primarily into solid dosage forms, with particular emphasis on extended-release formulations that maintain consistent therapeutic levels throughout daily patient routines. The ingredient's proven stability and broad compatibility make it suitable for various sophisticated drug delivery systems, serving diverse patient populations across multiple therapeutic markets while consistently meeting international regulatory requirements for quality assurance and patient safety.

Businesses selecting our Tolterodine Tartrate API gain access to a dependable supply chain characterized by consistent quality and reliable performance for specific manufacturing requirements. Our product provides pharmaceutical companies with the crucial assurance of batch-to-batch consistency, essential for maintaining optimal drug efficacy and regulatory compliance throughout production cycles. The API's thoroughly documented stability profile significantly reduces manufacturing risks while its competitive pricing structure supports both large-scale production operations and smaller batch requirements effectively. We deliver comprehensive documentation and professional support services that streamline the entire drug development process, establishing our Tolterodine Tartrate as the optimal choice for businesses seeking trustworthy API partnerships within the competitive pharmaceutical marketplace.

Key Features:
- High-purity muscarinic receptor antagonist with precise molecular weight of 475.6
- White crystalline powder formulation with pKa value of 9.87 and water solubility 12 mg/mL
- Demonstrated solubility in methanol, slight solubility in ethanol, and insolubility in toluene
- Consistent partition coefficient (Log D) of 1.83 at pH 7.3 between n-octanol and water
- Reliable quality with strict adherence to pharmaceutical manufacturing standards

Benefits:
- Consistent therapeutic effectiveness for overactive bladder symptom management
- Enhanced formulation flexibility for various drug delivery system applications
- Reduced manufacturing risks through documented stability and purity profiles
- Regulatory compliance support with comprehensive quality documentation
- Cost-effective production solutions for both generic and branded medications